Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications (Q38663736)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications |
scientific article |
Statements
1 reference
Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications (English)
1 reference
Jothilatha Krishnamoorthy
1 reference
Kamindla Rajesh
1 reference
Farzaneh Mirzajani
1 reference
Polixenia Kesoglidou
1 reference
Andreas I Papadakis
1 reference
Antonis E Koromilas
1 reference
Identifiers
1 reference